Industries

The cosmetic and aesthetic procedures market is undergoing a significant transformation, driven by a shift away from invasive surgical interventions toward minimally invasive and non-invasive treatments. Traditional cosmetic surgeries are often associated with higher procedural risks, longer recovery times, and increased costs, whereas emerging tec...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...

The rise of centennial humans highlights a structural shift in demographics, economies, and care, driven by longer life expectancy and advances in healthcare. The global population is aging rapidly, with centenarians increasing at a faster rate, especially in aging societies such as Japan and parts of Europe, and gradually in countries such as Indi...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point where...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, neuromodulation systems, and diagnostic solutions industry. The issue features advanced medical devices such as intelligent drug delivery system, immersive therapeuti...

This study focuses on the global electrophysiology (EP) ablation devices market. It analyzes the market for catheter-based ablation technologies used primarily to treat cardiac arrhythmias (especially atrial fibrillation), including radiofrequency (RF), cryoablation, pulse field ablation (PFA), and emerging modalities.The global EP ablation devices...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...